deinrezept Logo
All Medications
Mounjaro
Gewichtsabnahme & Übergewicht

Mounjaro®

The latest GLP-1/GIP dualagonist medication – with the highest weight loss in studies.

Prescription required
Quick navigation

What is Mounjaro?

Mounjaro is a new drug from Eli Lilly with the active ingredient Tirzepatid. It is the first approved dual agonist that simulates two intestinal hormones simultaneously: GLP-1 and GIP.

What makes Mounjaro special: Unlike Ozempic or Wegovy, which only imitate GLP-1, Tirzepatid acts on two hormone receptors. This leads to a stronger effect on weight and blood sugar.

Current approval:

  • Approved for type 2 diabetes in the EU
  • Approved for weight reduction (under the name Zepbound) in the USA
  • EU approval for obesity is expected

Study results: In the SURMOUNT study, participants lost an average of 20-22% of their body weight – more than any other approved drug.

Active Ingredients & Mechanism of Action

Active ingredient: Tirzepatid

Tirzepatid is a dual agonist that imitates two incense hormones:

GLP-1 action:

  • Enhanced saturation
  • Slowed gastric emptying
  • Improved insulin secretion

GIP action:

  • Additional appetite suppression
  • Improved fat metabolism
  • Synergistic effect with GLP 1

**The combination leads to:* *

  • Stronger appetite reduction as pure GLP-1 agonists
  • Higher weight loss
  • Better blood sugar control
  • Improved fat metabolism

SURMOUNT study results:

  • 15 mg: Average 22.5% weight loss
  • 10 mg: Average 21.4% weight loss
  • 5 mg: Average weight loss 16.0%

Who is it suitable for?

Current approval (EU):

  • Type 2 diabetes mellitus in adults
  • In combination with diet and exercise

Expected approval for obesity:

  • BMI ≥ 30 or
  • BMI ≥ 27 with accompanying disease

Specially promising for:

  • High weight loss patients
  • If other GLP-1 agonists do not work enough
  • In combination of diabetes and obesity

Not suitable for:

  • Type 1 diabetes
  • Pancreatitis in prehistory
  • Medulle thyroid cancer
  • Pregnancy

Available Dosages

dosing scheme:

  • Weeks 1-4: 2.5 mg weekly
  • Weeks 5-8: 5 mg weekly
  • Weeks 9-12: 7.5 mg weekly (optional)
  • Weeks 13-16: 10 mg weekly (optional)
  • From week 17: 12.5 or 15 mg weekly (optional)

Content boxes:

  • 5 mg, 10 mg or 15 mg depending on the effect and compatibility
  • Maximum dose: 15 mg once a week

** The dose is individually adjusted. Not everyone needs the maximum dose.

How to Take

Application:

  • One week, the same weekday
  • Subcutaneous injection
  • belly, thigh or upper arm
  • Independent meals

Pre-filled pen:

  • One-time pens per dose
  • Easy handling
  • Needle already integrated

Change weekday: Possible if at least 3 days have passed since the last injection.

Restoration:

  • In the refrigerator (2-8°C)
  • Can be stored once for 21 days at room temperature

Contraindications

Contraindications:

  • hypersensitivity to Tirzepatid
  • Medulläres thyroid carcinoma (or family history)
  • MEN 2 (Multiple endocrine neoplasia type 2)
  • Heavy gastrointestinal diseases

Preview at:

  • Pancreatitis in prehistory
  • Diabetic retinopathy
  • Gallensteinleiden
  • Heavy kidney or liver failure

pregnant:

  • Cancel at least 2 months before planned pregnancy

Possible Side Effects

Very common (>10%):

  • nausea
  • diarrhea
  • Blocking
  • Break.
  • stomach pain
  • Reduced appetite

Acid (1-10%):

  • Sodburning
  • Blowing
  • Repulse
  • fatigue
  • Hypoglycemia (in diabetics)
  • Reactions at the injection site

Occasionally:

  • gallstones
  • Increased heart rate
  • Hair loss

Selten, but seriously:

  • Pancreatitis
  • Heavy allergic reactions
  • Deterioration of diabetic retinopathy

** GI side effects are common at the beginning, but usually improve. Slow dosing helps.

Interactions

Insulin and sulfonylureas:

  • Increased hypoglycemia risk
  • Dose reduction of these medications necessary

Oral contraceptives:

  • Reduced recording possible
  • Additional prevention in GI complaints

Oral medicines in general:

  • Delayed intake due to slower gastric emptying

Frequently Asked Questions

Similar Medications

Is Mounjaro right for you?

A licensed doctor will review your information and issue a prescription if suitable. Discreet and secure.

Important Notice

This information does not replace medical advice. If you have questions about your health or the suitability of this medication, please consult a doctor or pharmacist.

Important Safety Information

This service operates under German pharmaceutical law (HWG). For risks and side effects, read the package leaflet and consult your doctor or pharmacist. All medications are dispensed from a licensed pharmacy in Germany.